Danish drugmaker Novo Nordisk (NVO) (OTCPK:NONOF) and AI-focused biotech Valo Health announced Wednesday an agreement to ...

Drugs for metabolic diseases, vaccines and cancer therapies feature among new product launches this year that could top $1 ...

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care ...

Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A new study reveals that junk food and drug use are hindering life expectancy gains in the U.S., despite technological ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...